Liver transplantation at the Miami Transplant Institute: a 14-year single-center experience.

J. Moon; E. Island; D. Weppler; T. Kato; A. Tekin; G. Selvaggi; N. Nakamura; P. Ruiz; S. Nishida; D. Levi; P. Martin; E. Schiff; A. G. Tzakis

Liver transplantation at the Miami Transplant Institute: a 14-year single-center experience.

J. Moon, E. Island, D. Weppler, T. Kato, A. Tekin, G. Selvaggi, N. Nakamura, P. Ruiz, S. Nishida, D. Levi, P. Martin, E. Schiff, A. G. Tzakis

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

The clinical outcome of LT has improved significantly with refinements in surgical skill and immunosuppressive agents. Over the past decade, nationally most LT centers have improved their standard care in LT. As a result, short-term survival after LT has increased remarkably. However, recurrence of original liver disease, chronic rejection, and the adverse effect of immunosuppressive agents still impose significant limitations on long-term survival. Here at the MTI, it is our mission to continue technical innovation, improve the management of hepatitis C patients, search for better immunosuppressive protocols, and work towards achieving tolerance after LT to improve the long-term outcome.

Original language	English (US)
Pages (from-to)	155-164
Number of pages	10
Journal	Clinical transplants
State	Published - 2007

ASJC Scopus subject areas

Medicine(all)

Access to Document

Fingerprint Dive into the research topics of 'Liver transplantation at the Miami Transplant Institute: a 14-year single-center experience.'. Together they form a unique fingerprint.

Cite this

@article{ec6d529b214f41cb869f2b39b30fafbb,

title = "Liver transplantation at the Miami Transplant Institute: a 14-year single-center experience.",

abstract = "The clinical outcome of LT has improved significantly with refinements in surgical skill and immunosuppressive agents. Over the past decade, nationally most LT centers have improved their standard care in LT. As a result, short-term survival after LT has increased remarkably. However, recurrence of original liver disease, chronic rejection, and the adverse effect of immunosuppressive agents still impose significant limitations on long-term survival. Here at the MTI, it is our mission to continue technical innovation, improve the management of hepatitis C patients, search for better immunosuppressive protocols, and work towards achieving tolerance after LT to improve the long-term outcome.",

author = "J. Moon and E. Island and D. Weppler and T. Kato and A. Tekin and G. Selvaggi and N. Nakamura and P. Ruiz and S. Nishida and D. Levi and P. Martin and E. Schiff and Tzakis, {A. G.}",

year = "2007",

language = "English (US)",

pages = "155--164",

journal = "Clinical transplants",

issn = "0890-9016",

publisher = "UCLA Immunogenetics Center",

}

TY - JOUR

T1 - Liver transplantation at the Miami Transplant Institute

T2 - a 14-year single-center experience.

AU - Moon, J.

AU - Island, E.

AU - Weppler, D.

AU - Kato, T.

AU - Tekin, A.

AU - Selvaggi, G.

AU - Nakamura, N.

AU - Ruiz, P.

AU - Nishida, S.

AU - Levi, D.

AU - Martin, P.

AU - Schiff, E.

AU - Tzakis, A. G.

PY - 2007

Y1 - 2007

N2 - The clinical outcome of LT has improved significantly with refinements in surgical skill and immunosuppressive agents. Over the past decade, nationally most LT centers have improved their standard care in LT. As a result, short-term survival after LT has increased remarkably. However, recurrence of original liver disease, chronic rejection, and the adverse effect of immunosuppressive agents still impose significant limitations on long-term survival. Here at the MTI, it is our mission to continue technical innovation, improve the management of hepatitis C patients, search for better immunosuppressive protocols, and work towards achieving tolerance after LT to improve the long-term outcome.

AB - The clinical outcome of LT has improved significantly with refinements in surgical skill and immunosuppressive agents. Over the past decade, nationally most LT centers have improved their standard care in LT. As a result, short-term survival after LT has increased remarkably. However, recurrence of original liver disease, chronic rejection, and the adverse effect of immunosuppressive agents still impose significant limitations on long-term survival. Here at the MTI, it is our mission to continue technical innovation, improve the management of hepatitis C patients, search for better immunosuppressive protocols, and work towards achieving tolerance after LT to improve the long-term outcome.

UR - http://www.scopus.com/inward/record.url?scp=49149090278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49149090278&partnerID=8YFLogxK

M3 - Review article

C2 - 18637467

AN - SCOPUS:49149090278

SP - 155

EP - 164

JO - Clinical transplants

JF - Clinical transplants

SN - 0890-9016

ER -